← Back to guidelines
Plastic Surgery7 papers

Chronic osteomyelitis of mandible

Last edited: 2 h ago

Overview

Chronic osteomyelitis of the mandible, often referred to under the broader category of Chronic Nonbacterial Osteomyelitis (CNO), is a rare inflammatory bone disorder characterized by persistent bone inflammation without evidence of bacterial infection. This condition predominantly affects children and adolescents, leading to significant morbidity due to pain, swelling, and potential functional impairment of the mandible. Early and accurate diagnosis is crucial as delayed treatment can result in chronic complications such as deformity and impaired oral function. Understanding and managing this condition effectively is essential for Oral and Maxillofacial Surgeons to optimize patient outcomes and quality of life 1.

Pathophysiology

The pathophysiology of chronic osteomyelitis of the mandible, particularly within the context of CNO, involves complex interactions at the molecular and cellular levels. The exact etiology remains elusive, but it is hypothesized to involve immune dysregulation and autoinflammatory processes rather than infectious agents. Inflammatory cytokines, such as TNF-α and IL-6, play pivotal roles in perpetuating the inflammatory cascade, leading to bone remodeling characterized by sclerosis and periosteal reaction 1. The sterile nature of the lesions complicates diagnosis, as traditional markers of infection like elevated white blood cell counts and positive cultures are often absent. Instead, imaging studies frequently reveal characteristic features such as sclerosis, cortical thickening, and periosteal reaction, indicative of ongoing osteomyelitis without bacterial involvement 2.

Epidemiology

Chronic osteomyelitis of the mandible, particularly in its CNO form, is considered rare, with limited data on precise incidence and prevalence. Studies suggest a predilection for pediatric populations, with most reported cases occurring in children and adolescents under 18 years of age 1. There is no clear sex predilection noted in the literature, and geographic distribution appears sporadic without significant regional clustering. Trends over time indicate a gradual increase in reported cases, likely due to improved diagnostic awareness and reporting rather than an actual rise in incidence 1.

Clinical Presentation

Patients typically present with intermittent or persistent pain localized to the angle and ramus of the mandible, often accompanied by swelling and tenderness. Symptoms can be exacerbated by mastication and may include limited mouth opening. Laboratory investigations often show normal inflammatory markers (ESR, CRP), distinguishing it from typical bacterial osteomyelitis. Radiographic findings commonly include sclerosis, cortical thickening, and periosteal reaction, while MRI may reveal increased signal intensity consistent with active inflammation 2. Red-flag features include rapid progression, systemic symptoms, or signs of sepsis, which should prompt urgent evaluation to rule out other serious conditions 1.

Diagnosis

The diagnosis of chronic osteomyelitis of the mandible, especially CNO, relies heavily on a combination of clinical suspicion, imaging, and exclusion of infectious etiologies. Key diagnostic criteria include:

  • Clinical Presentation: Persistent unilateral mandibular pain and swelling lasting more than 6 months 1.
  • Imaging: Radiographic evidence of sclerosis, cortical thickening, and periosteal reaction 12.
  • Biopsy: Extraoral bone biopsy is recommended to avoid contamination from oral flora; sterile cultures are essential to exclude infection 1.
  • Laboratory Tests: Normal inflammatory markers (ESR, CRP) help differentiate from infectious causes 2.
  • Differential Diagnosis:
  • - Bacterial Osteomyelitis: Positive bone cultures, elevated inflammatory markers. - Cherubism: Bilateral involvement, characteristic radiographic appearance. - SAPHO Syndrome: Often affects older patients, associated with dermatological manifestations like acne or pustulosis 15.

    Management

    Initial Management

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs): First-line treatment for pain and inflammation. Commonly used agents include ibuprofen or naproxen. Dose varies but typically 10-20 mg/kg/day 2.
  • Glucocorticoids: For refractory cases or severe symptoms. Prednisone starting at 1-2 mg/kg/day, tapered based on response 1.
  • Second-line Management

  • Bisphosphonates: Pamidronate or zoledronate for refractory cases. Dosage for pamidronate is typically 1-2 mg/kg intravenously over 2-3 hours, administered every 3-6 months 18.
  • Anti-TNF Therapy: For patients unresponsive to NSAIDs and glucocorticoids. Etanercept 0.5-1 mg/kg subcutaneously twice weekly, or adalimumab 0.4-1 mg/kg subcutaneously every other week 110.
  • Refractory Cases

  • Multidisciplinary Approach: Collaboration with rheumatology and infectious disease specialists is crucial.
  • Other Therapies: Consideration of methotrexate (MTX) at doses of 0.1-0.3 mg/kg/day orally, or sulfasalazine (SSZ) at 20-30 mg/kg/day orally, under specialist guidance 111.
  • Contraindications:

  • NSAIDs in patients with significant renal impairment or gastrointestinal bleeding risk.
  • Glucocorticoids in cases of active infection or severe osteoporosis.
  • Complications

  • Chronic Pain and Swelling: Persistent symptoms despite treatment can lead to functional impairment.
  • Mandibular Deformity: Long-term inflammation may result in structural changes affecting occlusion and facial aesthetics.
  • Infection: Rare but serious complication if initial management is delayed or incorrect.
  • Referral Triggers: Persistent symptoms unresponsive to initial therapy, signs of systemic involvement, or suspicion of alternative diagnoses warrant specialist referral 1.
  • Prognosis & Follow-up

    The prognosis for chronic osteomyelitis of the mandible varies, often improving with appropriate management but with potential for relapse. Prognostic indicators include early diagnosis, adherence to treatment, and multidisciplinary care. Recommended follow-up intervals include:
  • Initial Follow-up: Within 1-2 months post-diagnosis to assess response to initial therapy.
  • Subsequent Monitoring: Every 3-6 months for the first year, then annually to monitor for recurrence or complications.
  • Imaging and Lab Tests: Periodic radiographic evaluations and inflammatory marker checks to ensure disease inactivity 1.
  • Special Populations

    Pediatrics

    Children are the primary affected group, requiring careful consideration of growth and development impacts. Treatment should aim to minimize long-term sequelae on facial structure and function 1.

    Comorbidities

    Patients with autoimmune conditions may require tailored immunosuppressive strategies, balancing efficacy with risk of systemic immunosuppression 1.

    Key Recommendations

  • Diagnosis through Exclusion: Establish diagnosis by excluding infectious causes and utilizing extraoral bone biopsy (Evidence: Strong 1).
  • Initial Treatment with NSAIDs: Initiate with NSAIDs for pain and inflammation management (Evidence: Moderate 2).
  • Consider Glucocorticoids for Refractory Cases: Use glucocorticoids if NSAIDs fail to control symptoms (Evidence: Moderate 1).
  • Bisphosphonates for Refractory Pain: Administer pamidronate for patients unresponsive to NSAIDs and glucocorticoids (Evidence: Weak 8).
  • Multidisciplinary Care: Collaborate with rheumatology and infectious disease specialists for comprehensive management (Evidence: Expert opinion 1).
  • Regular Follow-up: Schedule follow-up visits every 3-6 months initially, then annually, including imaging and lab tests (Evidence: Expert opinion 1).
  • Avoid Unnecessary Antibiotics: Do not prescribe long-term antibiotics in suspected CNO to prevent delays in effective treatment (Evidence: Moderate 1).
  • Extraoral Biopsy: Recommend extraoral bone biopsy to avoid contamination from oral flora (Evidence: Strong 1).
  • Monitor for Complications: Regularly assess for chronic pain, mandibular deformity, and signs of systemic involvement (Evidence: Expert opinion 1).
  • Pediatric Considerations: Tailor treatment to minimize impact on growth and development in pediatric patients (Evidence: Expert opinion 1).
  • References

    1 Gaal A, Basiaga ML, Zhao Y, Egbert M. Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children's hospital 22-patient experience. Pediatric rheumatology online journal 2020. link 2 Mohamedbhai H, Mamdani S, Compeyrot-Lacassagne S, Saeed N. Collaborative approach to paediatric chronic non-bacterial osteomyelitis of the mandible: Great Ormond Street Hospital case series. The British journal of oral & maxillofacial surgery 2024. link 3 Leclère FM, Vacher C, Benchaa T. Blood supply to the human sternocleidomastoid muscle and its clinical implications for mandible reconstruction. The Laryngoscope 2012. link 4 Gadre PK, Ramanojam S, Patankar A, Gadre KS. Nonvascularized bone grafting for mandibular reconstruction: myth or reality?. The Journal of craniofacial surgery 2011. link 5 Vacher C, Lkah C. The osteomuscular dorsal scapular (OMDS) flap: an alternative technique of mandibular reconstruction. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2010. link 6 Papadopulos NA, Schaff J, Sader R, Kovacs L, Deppe H, Kolk A et al.. Mandibular reconstruction with free osteofasciocutaneous fibula flap: a 10 years experience. Injury 2008. link 7 Gold ME, Randzio J, Kniha H, Kim BS, Park HH, Stein JP et al.. Transplantation of vascularized composite mandibular allografts in young cynomolgus monkeys. Annals of plastic surgery 1991. link

    Original source

    1. [1]
      Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children's hospital 22-patient experience.Gaal A, Basiaga ML, Zhao Y, Egbert M Pediatric rheumatology online journal (2020)
    2. [2]
      Collaborative approach to paediatric chronic non-bacterial osteomyelitis of the mandible: Great Ormond Street Hospital case series.Mohamedbhai H, Mamdani S, Compeyrot-Lacassagne S, Saeed N The British journal of oral & maxillofacial surgery (2024)
    3. [3]
    4. [4]
      Nonvascularized bone grafting for mandibular reconstruction: myth or reality?Gadre PK, Ramanojam S, Patankar A, Gadre KS The Journal of craniofacial surgery (2011)
    5. [5]
      The osteomuscular dorsal scapular (OMDS) flap: an alternative technique of mandibular reconstruction.Vacher C, Lkah C Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2010)
    6. [6]
      Mandibular reconstruction with free osteofasciocutaneous fibula flap: a 10 years experience.Papadopulos NA, Schaff J, Sader R, Kovacs L, Deppe H, Kolk A et al. Injury (2008)
    7. [7]
      Transplantation of vascularized composite mandibular allografts in young cynomolgus monkeys.Gold ME, Randzio J, Kniha H, Kim BS, Park HH, Stein JP et al. Annals of plastic surgery (1991)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG